Peripheral blood mononuclear cells, CD4+ T cells and monocytes obtained from patients with multiple sclerosis (MS) have been reported to have decreased Nurr1 gene expression [107, 108]. The gene discussed is NR4A2; the disease is myeloid sarcoma.